NCT06804876

COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 107 (actual)
• Sponsor: Zhejiang University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Hypoxia represents the prevailing adverse occurrence during the sedation of patients undergoing gastrointestinal endoscopy with propofol. This is particularly true for obese patients, who have a higher incidence of hypoxia. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bite block , oxygenation support, and oropharyngeal airway management. This device has been purposefully designed to cater to the unique requirements of endoscopic procedures. The principal objective of this study is to assess the efficacy of the COMBO Endoscopy Oropharyngeal Airway in reducing the incidence of hypoxia in obese patients undergoing gastrointestinal endoscopy under sedation.

Conditions

• Hypoxia
• Esophageal Cancer
• Colon Cancer
• Gastric Cancer

Interventions

Type	Name	Description
DEVICE	the COMBO Endoscopy Oropharyngeal Airway	Using the COMBO Endoscopy Oropharyngeal Airway for oxygenation.

Timeline

• Start date: 2025-02-04
• Primary completion: 2025-03-26
• Completion: 2025-03-26
• First posted: 2025-02-03
• Last updated: 2025-05-21

Locations

1 site across 1 country: China